SEL1L and Parkinson disease: Also, studies should examine whether miR-101 or SEL1L levels change with the use of 1-methyl-4-phenylpyridinium, which has also been used to generate a cellular model of PD, or whether miR-101 and SEL1L levels change in a mouse model of PD.